Back to search

Article

Targeted Therapy Improves Real-World Survival in Patients with Molecularly Matched Advanced Biliary Tract Cancer

2025-10-12

Abstract excerpt

<title>Abstract</title> <p>Molecular profiling reveals that up to 40% of advanced biliary tract cancers (BTCs) harbor actionable genomic alterations amenable to matched targeted therapies. However, conventional trial designs typically evaluate these agents in pretreated populations, resulting in approvals for later-line use. Notably, 25–44% of patients with advanced BTC may become ineligible for treatment after f...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c6244175-5d52-5751-a141-9b3c045653a8
DOI
10.21203/rs.3.rs-7744614/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeted Therapy Improves Real-World Survival in Patients with Molecularly Matched Advanced Biliary Tract CancerDOI 10.21203/rs.3.rs-7744614/v1
Real-world Analysis of Treatment Patterns, Clinical Outcomes, and Molecular Profiling in Advanced Biliary Tract Cancer.Semantic proximity
Genomics driven precision oncology in advanced biliary tract cancer improves survival.Semantic proximity
Prognostic impact of genomically matched therapy for solid cancers using real-world data from a provincial hospital in JapanSemantic proximity
Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial.Semantic proximity
Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving ParadigmSemantic proximity
Targeted deep sequencing contributes to guiding personalized targeted therapy for advanced biliary tract cancer patients with non‑radical resection: A real‑world study.Semantic proximity
Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter studySemantic proximity
Translating cancer genomics for precision oncology in biliary tract cancers.Semantic proximity
Coexistence of TP53 and KRAS mutations identifies a molecular subset of biliary tract cancer with poor overall survival after first-line immunochemotherapy.Semantic proximity
Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targetsSemantic proximity
Matching genomic molecular aberrations with molecular targeted agents: Are biliary tract cancers an ideal playground?Semantic proximity
Molecular profiling of biliary tract cancer: a target rich diseaseSemantic proximity
Select a neighboring publication to make it the new centre.